Bharat Biotech's Covaxin gets Subject Expert Committee (SEC) approval for emergency use02 Jan, 2021, 07.41 PM ISTCovaxin for kids: SEC approves Bharat Biotech's COVID vaccine for children from 2 to 18 yrs12 Oct, 2021, 01.50 PM ISTUS SEC denies bitcoin ETF has been approved, says account on X was hacked10 Jan, 2024, 07.45 AM ISTUS stocks: US market indexes fall over 1%, dragged by tech and Iran war worries
United Naga Council calls 24-hour shutdown after six abducted Nagas found dead
RBI issues draft CCR framework aligned with global standards
Neighbours and world leaders hail PM Modi's milestone
West Bengal: CM Suvendu Adhikari keeps home, Swapan Dasgupta gets finance, Tapas Roy industry
Japan's Chubu Electric set to buy $150 million stake in Continuum Green
Reliance Foundation secures major win as ITAT overturns cancellation of charity registration
For Viksit Bharat, next decade must be one of excellence, not just achievement: PM Modi
At Beihouse, Beirut's spirit of resilience is on the menu
Airtel to continue its postpaid plan despite backlash over 'slicing'
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service